|
86
|
260
|
7bjvA |
Crystal structure of the ligand-binding domains of the heterodimer ecr/usp bound to the synthetic agonist byi09181 |
|
87
|
260
|
7bjuA |
Crystal structure of the ligand-binding domains of the heterodimer ecr/usp bound to the synthetic agonist byi08346 |
|
92
|
269
|
7lotA |
Human ppar gamma lbd in complex with tetrazole compound n-{3-[(4-methylbenzyl)oxy]benzyl}-2h-tetrazol-5-amine. |
|
97
|
269
|
6vznA |
Crystal structure of human ppargamma ligand binding domain y473e mutant |
|
94
|
268
|
6vzmA |
Crystal structure of human ppargamma ligand binding domain y473e mutant in complex with darglitazone |
|
95
|
268
|
6vzlA |
Crystal structure of human ppargamma ligand binding domain in complex with gw1929 |
|
94
|
265
|
7kqjA |
Crystal structure of rar-related orphan receptor c (nhis-rorgt(244-487)-l6-src1(678-692) in complex with a novel tricyclic-carbocylic rorgt inverse agonist |
|
94
|
270
|
6vzoA |
Crystal structure of human ppargamma ligand binding domain (protein delipidated by denature and refold) |
|
93
|
268
|
7jqgA |
Crystal structure of human ppargamma ligand binding domain y473e mutant in complex with gw1929 |
|
75
|
197
|
6wmqA |
Crystal structure of human rev-erbbeta ligand binding domain co-bound to heme and ncor id1 peptide |
|
92
|
299
|
6xzkA |
Structure of zvdr lbd-calcitriol in complex with chimera 13 |
|
96
|
299
|
6xzhA |
Structure of zvdr lbd-calcitriol in complex with chimera 10 |
|
95
|
299
|
6xzvA |
Structure of zvdr lbd-calcitriol in complex with chimera 18 |
|
97
|
299
|
6xzjA |
Structure of zvdr lbd-calcitriol in complex with chimera 12 |
|
78
|
196
|
6wmsA |
Crystal structure of human rev-erbbeta ligand binding domain co-bound to heme and ncor id2 peptide |
|
98
|
299
|
6xziA |
Structure of zvdr lbd-calcitriol in complex with chimera 11 |
|
103
|
270
|
6kb9A |
X-ray structure of human pparalpha ligand binding domain-pemafibrate co-crystals obtained by cross-seeding |
|
106
|
270
|
6lxcA |
X-ray structure of human pparalpha ligand binding domain-saroglitazar co-crystals obtained by delipidation and cross-seeding |
|
108
|
270
|
6lx4A |
X-ray structure of human pparalpha ligand binding domain-fenofibric acid co-crystals obtained by delipidation and co-crystallization |
|
104
|
270
|
6kayA |
X-ray structure of human pparalpha ligand binding domain-gw7647 co-crystals obtained by soaking |
|
111
|
268
|
6kb5A |
X-ray structure of human pparalpha ligand binding domain-5,8,11,14-eicosatetraynoic acid (etya) co-crystals obtained by delipidation and cross-seeding |
|
99
|
259
|
6locA |
Crystal structure of rorgammat with ligand c46d bound |
|
108
|
270
|
6lx9A |
X-ray structure of human pparalpha ligand binding domain-arachidonic acid co-crystals obtained by delipidation and cross-seeding |
|
108
|
270
|
6kb1A |
X-ray structure of human pparalpha ligand binding domain-tetradecylthioacetic acid (tta) co-crystals obtained by soaking |
|
88
|
232
|
6lb4A |
Crystal structure of dimeric rxr-lbd complexed with net-3me and tif2 co-activator |
|
83
|
230
|
6lb6A |
Crystal structure of dimeric rxr-lbd complexed with partial agonist net-4ib and tif2 co-activator |
|
98
|
259
|
6lo9A |
Crystal structure of rorgammat with ligand c46d bound |
|
112
|
267
|
6lx6A |
X-ray structure of human pparalpha ligand binding domain-palmitic acid co-crystals obtained by delipidation and cross-seeding |
|
104
|
270
|
6kypA |
X-ray structure of human pparalpha ligand binding domain-gw9662-clofibric acid co-crystals obtained by delipidation and co-crystallization |
|
109
|
270
|
6lx7A |
X-ray structure of human pparalpha ligand binding domain-stearic acid co-crystals obtained by delipidation and cross-seeding |
|
107
|
270
|
6lxaA |
X-ray structure of human pparalpha ligand binding domain-eicosapentaenoic acid (epa) co-crystals obtained by delipidation and cross-seeding |
|
108
|
270
|
6kb6A |
X-ray structure of human pparalpha ligand binding domain-tetradecylthioacetic acid (tta) co-crystals obtained by delipidation and cross-seeding |
|
108
|
267
|
6kb0A |
X-ray structure of human pparalpha ligand binding domain-5,8,11,14-eicosatetraynoic acid (etya) co-crystals obtained by soaking |
|
107
|
267
|
6kbaA |
X-ray structure of human pparalpha ligand binding domain-wy14643 co-crystals obtained by co-crystallization |
|
110
|
267
|
6lx8A |
X-ray structure of human pparalpha ligand binding domain-oleic acid co-crystals obtained by delipidation and cross-seeding |
|
104
|
270
|
6l38A |
X-ray structure of human pparalpha ligand binding domain-gw9662-gemfibrozil co-crystals obtained by delipidation and co-crystallization |
|
109
|
270
|
6kb3A |
X-ray structure of human pparalpha ligand binding domain-gw7647 co-crystals obtained by delipidation and cross-seeding |
|
108
|
270
|
6kb4A |
X-ray structure of human pparalpha ligand binding domain-pemafibrate co-crystals obtained by delipidation and cross-seeding |
|
101
|
270
|
6l37A |
X-ray structure of human pparalpha ligand binding domain-gw9662-ciprofibrate co-crystals obtained by delipidation and co-crystallization |
|
102
|
269
|
6lxbA |
X-ray structure of human pparalpha ligand binding domain-saroglitazar co-crystals obtained by soaking |
|
112
|
267
|
6kb7A |
X-ray structure of human pparalpha ligand binding domain-wy14643 co-crystals obtained by delipidation and cross-seeding |
|
102
|
294
|
7axaA |
Crystal structure of the hpxr-lbd in complex with clotrimazole |
|
102
|
295
|
7axlA |
Crystal structure of the hpxr-lbd in complex with estradiol and heptachlor endo-epoxide |
|
103
|
294
|
7axhA |
Crystal structure of the hpxr-lbd in complex with alpha-zearalanol |
|
86
|
229
|
7b88A |
Crystal structure of retinoic acid receptor alpha (rxra) in complexed with s99 inhibitor |
|
87
|
244
|
7kcaA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with raloxifene |
|
107
|
270
|
7bq0A |
X-ray structure of human pparalpha ligand binding domain-fenofibric acid-src1 coactivator peptide co-crystals obtained by delipidation and co-crystallization |
|
89
|
244
|
7kcdA |
Estrogen receptor alpha ligand binding domain in complex with a methylated lasofoxifene derivative that increases receptor resonance time in the nucleus of breast cancer cells |
|
94
|
268
|
6zlyA |
Crystal structure of the complex between ppargamma lbd and the ligand nv1362 (7a) |
|
74
|
195
|
7cfoA |
Crystal structure of human rxralpha ligand binding domain complexed with cbtf-ee. |
